Search Results - "Irby, Rosalyn B"

Refine Results
  1. 1

    Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway by Krishnegowda, Gowdahalli, Prakasha Gowda, A.S., Tagaram, Hephzibah Rani S., Carroll, Kevin F. Staveley-O’, Irby, Rosalyn B., Sharma, Arun K., Amin, Shantu

    Published in Bioorganic & medicinal chemistry (15-10-2011)
    “…A novel series of 5,7-dibromoisatin analogs were synthesized and evaluated for their cytotoxicities against four human cancer cell lines including colon HT29,…”
    Get full text
    Journal Article
  2. 2

    The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer by Allen, Joshua E, Gallant, Jean-Nicolas, Dicker, David T, Amin, Shantu, Irby, Rosalyn B, Sharma, Arun K, El-Deiry, Wafik S

    Published in PloS one (12-03-2013)
    “…Phenylbutyl isoselenocyanate (ISC-4) is an Akt inhibitor with demonstrated preclinical efficacy against melanoma and colon cancer. In this study, we sought to…”
    Get full text
    Journal Article
  3. 3

    Epidermal growth factor receptor revisited: Prognostic marker or target for therapy? by Irby, Rosalyn B.

    Published in Cancer biology & therapy (01-09-2010)
    “…Commentary to: EGFR expression variance in paired colorectal cancer primary and metastatic tumors Nirit Yarom, Celia Marginean, Terence Moyana, Ivan…”
    Get full text
    Journal Article
  4. 4

    Activating SRC mutation in a subset of advanced human colon cancers by Yeatman, Timothy J, Irby, Rosalyn B, Mao, Weiguang, Coppola, Domenico, Kang, Jimmy, Loubeau, Jean Marc, Trudeau, Walter, Karl, Richard, Fujita, Donald J, Jove, Richard

    Published in Nature genetics (01-02-1999)
    “…The discovery of Rous sarcoma virus (RSV) led to the identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been implicated in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells by Nguyen, Jeffrey Q., Irby, Rosalyn B.

    Published in Cancer biology & therapy (02-01-2017)
    “…The prostate apoptosis response protein 4 (Par-4) is a tumor-suppressor that has been shown to induce cancer-cell selective apoptosis in a variety of cancers…”
    Get full text
    Journal Article
  7. 7

    Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU by Kline, Christina Leah, Shanmugavelandy, Sriram S., Kester, Mark, Irby, Rosalyn B.

    Published in Cancer biology & therapy (01-10-2009)
    “…The prostate apoptosis response protein 4 (Par-4), a tumor suppressor, has been shown to induce apoptosis in cancer cells. While reduced Par-4 expression has…”
    Get full text
    Journal Article
  8. 8

    Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer by Allen, Joshua E., Gallant, Jean-Nicolas, Dicker, David T., Amin, Shantu, Irby, Rosalyn B., Sharma, Arun K., El-Deiry, Wafik S.

    Published in PloS one (07-11-2013)
    “…Summary of combinatorial effects of ISC-4 with approved antitumor agents. (2013) Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in…”
    Get full text
    Journal Article
  9. 9

    Identification of Src transformation fingerprint in human colon cancer by Malek, Renae L, Irby, Rosalyn B, Guo, Qingbin M, Lee, Kerry, Wong, Sylvia, He, Mei, Tsai, Jennifer, Frank, Bryan, Liu, Edison T, Quackenbush, John, Jove, Richard, Yeatman, Timothy J, Lee, Norman H

    Published in Oncogene (17-10-2002)
    “…We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell…”
    Get full text
    Journal Article
  10. 10

    Iterative microarray and RNA interference-based interrogation of the Src-induced invasive phenotype by IRBY, Rosalyn B, MALEK, Renae L, BLOOM, Greg, TSAI, Jennifer, LETWIN, Noah, FRANK, Bryan C, VERRATTI, Kathleen, YEATMAN, Timothy J, LEE, Norman H

    Published in Cancer research (Chicago, Ill.) (01-03-2005)
    “…Src kinase has long been recognized as a factor in the progression of colorectal cancer and seems to play a specific role in the development of the metastatic…”
    Get full text
    Journal Article
  11. 11

    Role of Src expression and activation in human cancer by Irby, R B, Yeatman, T J

    Published in Oncogene (20-11-2000)
    “…Since the original identification of a transmissible agent responsible for the development of tumors in chickens, now known to be a retrovirus encoding the…”
    Get full text
    Journal Article
  12. 12

    The Akt Inhibitor ISC-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model by SHARMA, Arun K, KLINE, Christina L, BERG, Arthur, AMIN, Shantu, IRBY, Rosalyn B

    Published in Clinical cancer research (01-07-2011)
    “…Prostate apoptosis response protein-4 (Par-4) sensitizes cells to chemotherapy; however, Akt1 inactivates Par-4. Previously we showed that Par-4-overexpressing…”
    Get full text
    Journal Article
  13. 13

    Par-4 as a potential target for cancer therapy by Irby, Rosalyn B, Kline, Christina L B

    Published in Expert opinion on therapeutic targets (01-01-2013)
    “…Despite extensive research, cancer continues to be a leading cause of death worldwide and is expected to continue to rise as a result of an aging population…”
    Get more information
    Journal Article
  14. 14

    Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells by IRBY, Rosalyn B, YEATMAN, Timothy J

    Published in Cancer research (Chicago, Ill.) (01-05-2002)
    “…Src has been implicated in the development and progression of human colon cancer. Because the capacity for tumor cells to dissociate from the primary tumor is…”
    Get full text
    Journal Article
  15. 15

    The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU by Kline, Christina Leah B., Irby, Rosalyn B.

    Published in Apoptosis (London) (01-12-2011)
    “…The overexpression of the pro-apoptotic protein Prostate Apoptosis Response Protein-4 in colon cancer has been shown to increase response to the…”
    Get full text
    Journal Article
  16. 16

    Tumor Necrosis Factor α Induces p53 Up-regulated Modulator of Apoptosis Expression in Colorectal Cancer Cell Lines by Pastor, Danielle M, Irby, Rosalyn B, Poritz, Lisa S

    Published in Diseases of the colon & rectum (01-03-2010)
    “…PURPOSE:Inflammatory bowel disease (IBD)–associated colorectal carcinogenesis involves dysregulation of multiple cellular pathways, including p53 signaling and…”
    Get full text
    Journal Article
  17. 17

    Src kinase induces tumor formation in the c‐SRC C57BL/6 mouse by Kline, Christina Leah B., Jackson, Rosalind, Engelman, Robert, Pledger, Warren Jack, Yeatman, Timothy J., Irby, Rosalyn B.

    Published in International journal of cancer (15-06-2008)
    “…Src kinase has been linked as a causative agent in the progression of a number of cancers including colon, breast, lung and melanoma. Src protein and activity…”
    Get full text
    Journal Article
  18. 18

    Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression by Cook, Amy C., Tuck, Alan B., McCarthy, Susan, Turner, Joel G., Irby, Rosalyn B., Bloom, Gregory C., Yeatman, Timothy J., Chambers, Ann F.

    Published in Molecular carcinogenesis (01-08-2005)
    “…Tumor progression is a multistep process, which enables cells to evolve from benign to malignant tumors. This progression has been suggested to depend on six…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Src activity alters α3 integrin expression in colon tumor cells by Kline, Christina Leah B, Olson, Thomas L, Irby, Rosalyn B

    Published in Clinical & experimental metastasis (01-02-2009)
    “…Src kinase has been linked to increased motility in the progression and metastasis of human colon cancer, although the mechanisms are not fully understood…”
    Get full text
    Journal Article